Market Overview:
The global marine derived drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for marine-derived drugs for the treatment of various diseases, such as cancer and cardiovascular diseases. In addition, the growing awareness about the benefits of marine-derived drugs is also contributing to the growth of this market. The global marine derived drugs market can be segmented on the basis of type, application, and region. On the basis of type, this market can be divided into mollusk, sponge, tunicate fish and others segments. The mollusk segment is expected to account for a major share in terms revenue in 2018 owing to its wide range applications in drug discovery and development processes across different therapeutic areas such as oncology and cardiology among others. By application, antitumor drugs are anticipated witness highest growth rate over next few years due high prevalence cancer cases coupled with increasing R&D investments by key players operating in this space across globe .
Product Definition:
A Marine Derived Drug is a term used to describe a drug that has been isolated from marine life. Marine derived drugs are important because they can be used to treat diseases that have been resistant to traditional treatments.
Mollusk:
Mollusks are gastropods that live in the sea and have a soft body. The most commonly used mollusk for drug development is the abalone which has been used to develop antibiotics, anti-inflammatory drugs, blood pressure drugs and vaccines among others.
Sponge:
Sponge is a porous, hollow fiber that has been used as an absorbent for marine organisms. Marine sponges are used in the production of biopharmaceuticals such as vaccines and monoclonal antibodies owing to their ability to produce high levels of proteins. Sponge extracts have been reported to contain immunosuppressive and anti-inflammatory compounds which may be useful in the development of drugs targeting autoimmune diseases, inflammatory processes or cancer.
Application Insights:
The market is segmented based on application into antitumor drugs, anti-cardiovascular drugs, antibiotics, antidiabetic drugs and others. In 2017, the anti-cancer segment dominated the global marine derived drug market owing to increasing cancer cases across the globe. The rising number of cancer cases has led to a growing demand for marine derived anticancer drugs which are effective against resistant tumor cells.
Antitumor Drugs held a significant share in 2017 due to high incidence of various types of cancers such as lung cancer and breast carcinoma among women which have become difficult for conventional treatment methods to treat due to resistance developed by tumor cells. This trend is expected continue over the forecast period with introduction of new products with enhanced efficacy coupled with fewer side effects than conventional therapies that will further boost industry growth during future years.
Regional Analysis:
Asia Pacific dominated the global marine derived drugs market in 2017. The presence of a large number of manufacturers and suppliers coupled with increasing R&D activities in this region is expected to drive the market growth over the forecast period. In addition, high consumption of seafood is also driving demand for these products in this region. Increasing disposable income levels and growing consumer awareness regarding advanced therapies are some factors contributing to regional growth.
The Asia Pacific therapeutics sector has witnessed significant investment from various governments as well as private players over the past few years owing to its potential for rapid economic development along with an abundant supply of raw materials.
Growth Factors:
- Increasing demand for marine derived drugs for the treatment of various diseases such as cancer, arthritis, and Alzheimer's disease.
- Growing research and development activities in the field of marine derived drugs to develop novel therapeutics.
- Rising number of collaborations between pharmaceutical companies and research institutes to develop new marine-based drugs.
- increasing investment by government agencies in Marine Derived Drugs market research to find new sources for drug discovery
Scope Of The Report
Report Attributes
Report Details
Report Title
Marine Derived Drugs Market Research Report
By Type
Mollusk, Sponge, Tunicate, Fish, Others
By Application
Antitumor Drugs, Anti-Cardiovascul
By Companies
Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Marine Derived Drugs Market Report Segments:
The global Marine Derived Drugs market is segmented on the basis of:
Types
Mollusk, Sponge, Tunicate, Fish, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antitumor Drugs, Anti-Cardiovascul
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Seattle Genetics
- Eisai Co
- Tekada
- Pfizer
- Pharma Mar
- Johnson and Johnson
- GSK
- TerSera Therapeutics
- Teva
Highlights of The Marine Derived Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mollusk
- Sponge
- Tunicate
- Fish
- Others
- By Application:
- Antitumor Drugs
- Anti-Cardiovascul
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Marine Derived Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Marine derived drugs are medications that are derived from marine organisms. These medications can be used to treat a variety of medical conditions.
Some of the key players operating in the marine derived drugs market are Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva.
The marine derived drugs market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Marine Derived Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Marine Derived Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Marine Derived Drugs Market - Supply Chain
4.5. Global Marine Derived Drugs Market Forecast
4.5.1. Marine Derived Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Marine Derived Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Marine Derived Drugs Market Absolute $ Opportunity
5. Global Marine Derived Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Marine Derived Drugs Market Size and Volume Forecast by Type
5.3.1. Mollusk
5.3.2. Sponge
5.3.3. Tunicate
5.3.4. Fish
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Marine Derived Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Marine Derived Drugs Market Size and Volume Forecast by Application
6.3.1. Antitumor Drugs
6.3.2. Anti-Cardiovascul
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Marine Derived Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Marine Derived Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Marine Derived Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Marine Derived Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Marine Derived Drugs Demand Share Forecast, 2019-2029
9. North America Marine Derived Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Marine Derived Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Marine Derived Drugs Market Size and Volume Forecast by Application
9.4.1. Antitumor Drugs
9.4.2. Anti-Cardiovascul
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Marine Derived Drugs Market Size and Volume Forecast by Type
9.7.1. Mollusk
9.7.2. Sponge
9.7.3. Tunicate
9.7.4. Fish
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Marine Derived Drugs Demand Share Forecast, 2019-2029
10. Latin America Marine Derived Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Marine Derived Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Marine Derived Drugs Market Size and Volume Forecast by Application
10.4.1. Antitumor Drugs
10.4.2. Anti-Cardiovascul
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Marine Derived Drugs Market Size and Volume Forecast by Type
10.7.1. Mollusk
10.7.2. Sponge
10.7.3. Tunicate
10.7.4. Fish
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Marine Derived Drugs Demand Share Forecast, 2019-2029
11. Europe Marine Derived Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Marine Derived Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Marine Derived Drugs Market Size and Volume Forecast by Application
11.4.1. Antitumor Drugs
11.4.2. Anti-Cardiovascul
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Marine Derived Drugs Market Size and Volume Forecast by Type
11.7.1. Mollusk
11.7.2. Sponge
11.7.3. Tunicate
11.7.4. Fish
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Marine Derived Drugs Demand Share, 2019-2029
12. Asia Pacific Marine Derived Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Application
12.4.1. Antitumor Drugs
12.4.2. Anti-Cardiovascul
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Marine Derived Drugs Market Size and Volume Forecast by Type
12.7.1. Mollusk
12.7.2. Sponge
12.7.3. Tunicate
12.7.4. Fish
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Marine Derived Drugs Demand Share, 2019-2029
13. Middle East & Africa Marine Derived Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Application
13.4.1. Antitumor Drugs
13.4.2. Anti-Cardiovascul
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Marine Derived Drugs Market Size and Volume Forecast by Type
13.7.1. Mollusk
13.7.2. Sponge
13.7.3. Tunicate
13.7.4. Fish
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Marine Derived Drugs Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Marine Derived Drugs Market: Market Share Analysis
14.2. Marine Derived Drugs Distributors and Customers
14.3. Marine Derived Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Seattle Genetics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eisai Co
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tekada
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pharma Mar
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson and Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GSK
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. TerSera Therapeutics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Teva
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
